4//SEC Filing
Vivo Ventures V Affiliates Fund, L.P. 4
Accession 0001213900-19-021959
CIK 0001484565other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:46 PM ET
Size
14.1 KB
Accession
0001213900-19-021959
Insider Transaction Report
Form 4
Vivo Ventures Fund V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-10-31$1.55/sh−24,824$38,477→ 4,204,583 total(indirect: See Footnote) - Sale
Common Stock
2019-11-04$1.58/sh−214,682$339,198→ 3,894,990 total(indirect: See Footnote) - Sale
Common Stock
2019-11-01$1.55/sh−94,911$147,112→ 4,109,672 total(indirect: See Footnote)
Vivo Ventures V, LLC
10% Owner
Transactions
- Sale
Common Stock
2019-10-31$1.55/sh−24,824$38,477→ 4,204,583 total(indirect: See Footnote) - Sale
Common Stock
2019-11-04$1.58/sh−214,682$339,198→ 3,894,990 total(indirect: See Footnote) - Sale
Common Stock
2019-11-01$1.55/sh−94,911$147,112→ 4,109,672 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2019-10-31$1.55/sh−24,824$38,477→ 4,204,583 total(indirect: See Footnote) - Sale
Common Stock
2019-11-01$1.55/sh−94,911$147,112→ 4,109,672 total(indirect: See Footnote) - Sale
Common Stock
2019-11-04$1.58/sh−214,682$339,198→ 3,894,990 total(indirect: See Footnote)
Footnotes (4)
- [F1]The shares of common stock are held of record by Vivo Ventures Fund V, L.P. and Vivo Ventures V Affiliates Fund, L.P. ("Vivo Fund V"). Vivo Ventures V, LLC is the sole general partner of Vivo Fund V, and may be deemed to beneficially own the shares of common stock owned by Vivo Fund V. Vivo Ventures V, LLC disclaims beneficial ownership of the shares of Issuer held by Vivo Fund V, except to the extent of its pecuniary interest therein. The voting members of Vivo Ventures V, LLC are Frank Kung, Albert Cha and Edgar Engleman, none of whom has individual voting or investment power with respect to these shares and each of whom disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- [F2]The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Documents
Issuer
SOLENO THERAPEUTICS INC
CIK 0001484565
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001398936
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 5:46 PM ET
- Size
- 14.1 KB